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MTT assay. Expression of mRNA for chemokines and cytokines 
was analyzed by ribonuclease protection assay and expresion of 
mRNA for metaloprotease (MMP-1), by RT-PCR. NO production 
was evaluated by the Greiss Method and PGE2, IL-8 and IL-6 by 
ELISA. 
Results: Firstly, when we examined the individual effect of mito- 
chondrial inhibitors, we observed that antimycin A and oligomycin 
decrease cell viability in a dose- and time-dependent manner 
(at 48 h, antimycin A: 524-7 and oligomycin: 424-5 vs basal 
100%, n=6, p<0.01). However, the rest of MRC inhibitors (I, II, 
and IV) did not modified the viability. Secondly, we explored the 
chemokines and cytokines mRNA and we found that only an- 
timycin A and oligomycin induced in a dose-dependent manner 
the mRNA of chemokines IL-8 and MCP-1. Other chemokines 
such as, Rantes, 1-309, and IP-10 were not modified. Thereafter, 
we examined whether the rise in IL-8 mRNA in cultured chon- 
drocytes was accompanied by the synthesis of IL-8 protein and 
we found that it was induced by antimycin A and oligomycin (at 
24 h; basal, 624-14; antimycin A, 1354-34, oligomycin, 3254-12 
pg/ml/50.000 cells, n=4). In relation to cytokines evaluated we 
found that again, only antimycin A and oligomycin induced in a 
dose-dependent manner the mRNA of cytokines IL-6, IL-1 b; and 
IL-18. Other cytokines such as, IL-12, IL-10, IL-lb; orthe IL-1Ra 
were not significantly modified. The rest of inhibitors did not mod- 
ified the mRNA expression studied. Thereafther we determined 
that the rise in IL-6 mRNA in cultured chondrocytes was accom- 
panied by the synthesis of IL-6 protein (at 24 h; basal, 404-12; 
antimycin A, 1804-44, oligomycin, 4254-12 pg/ml/50.000 cells, 
n=4). When MMP-1 was examined, it was found that oligomycin 
increases significantly its expression in a dose-dependent man- 
ner.Thirdly, when we assesed NO and PGE2 production we found 
that neither inhibitor employed were able to modulate NO synthe- 
sis. However, in relation to PGE2, we described as antimycin A 
and oligomycin increase significantly PGE2 after 48 h of stim- 
ulation (basal, 1054-15; antimycin A, 8254-34 and oligomycin, 
11124-325 pg/ml/50.000 cells). 
Conclusion: These results show that mitochondrial dysfunction 
could modulate inflammatory response in human OA chondro- 
cytes and that inhibition of complex III and V could be especially 
relevant in relation to inflammatory response. These data could 
be important for a better understanding of the role of mitochon- 
dria in the pathogenesis of cartilage degradation. 
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Initial disorder in OA is the metabolic abnormalities of chondro- 
cyte characterized by secretion of proteinases, suppression of 
of matrix synthesis, and apoptosis of chondrocyte. It has been 
reported that OA is associated with underlying abnormalities in 
bone structure and mineralization. Analysis of Framingham study 
indicated that low serum levels of vitamin D appears to be as- 
sociated with an increased risk for progression of the knee OA. 
Association of early knee OA with a polymorphism of the vitamin 
D receptor gene is also shown. Objective of this study is to de- 
termine the effect of 1,25(OH)2D3 on chondrocyte cell death and 
the expression of apoptosis-related molecules in STR/ort mice, 
naturally developing OA model. 
Materials and Methods: Thirty nine male STR/ort mice were 
studied by randomly assigning them to two treatment groups 
in study of six months duration. 1,25(OH)2D3 (0.11~g/kg body 
weight)were administrated subcutaneously from 8 weeks of age 
and sacrificed 25 or 35 weeks of age. Toluidine blue stain- 
ing, TUNEL assay, and immunohistochemistry against apoptosis- 
related molecules including iNOS, TNF-~, TRAIL, caspase-3, 
FAS, DR-5 were performed on serial paraffin sections of the knee 
joint from mice. 
Results: Histological examination showed STR/ort mice exhib- 
ited OA lesions of knee joint at 35 weeks after birth, however 
no changes at 25 weeks. These OA lesions were suppressed 
in mice treated with 1,25(OH)2D3. TUNEL positive chondrocytes 
were observed frequently in control mice at 35 weeks after birth. 
1,25(OH)2D3 treatment decreased the number of TUNEL posi- 
tive chondrocytes. Immunohistological examination indicated that 
chondrocytes expressed iNOS, TNF-~, TRAIL, caspase-3, and 
FAS DR-5 at 35 weeks. 1,25(OH)2D3 treatment decreased num- 
ber of chondrocytes which were positive for these apoptosis- 
related molecules. Among these molecules, iNOS expression 
was suppressed most significantly with 1,25(OH)2D3 treatment. 
Discussion: In STR/ort mice, chondrocyte cell death is shown 
to be correlated with the progression of OA. Chondrocyte apop- 
tosis is induced with several molecules in vivo and in vitro. 
Present study indicated that 1,25(OH)2D3 suppressed chondro- 
cyte cell death. Administration of 1,25(OH)2D3 also significantly 
suppressed iNOS expression of chondrocyte. We suppose that 
inhibition of chondrocyte cell death may be the one of the path- 
way for the anti-OA effect of 1,25(OH)2D3 observed in this mice. 
Above results suggest 1,25(OH)2D3 may have therapeutic value 
for OA. 
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Purpose: Targeted remodeling of aged bone for repair of micro 
cracks is essential for maintenance of bone quality. How osteo- 
clasts target old bone in order to sustain the quality of the skele- 
ton by constant remodelling is currently not known. 
We investigated whether old bones accumulate signals, which 
target the bone for remodeling by osteoclasts. For this purpose, 
human osteoclast precursors were assessed for their ability to 
survive, adhere, differentiate and resorb old versus young bone. 
Methods: Human CD14+ monocytes were isolated by magnetic 
bead sorting. Differentiation of osteoclasts on young (9-months) 
and old (8-years) bone slices was tested, by culturing the mono- 
cytes in the presence of RANKL and M-CSF for 28 days. Differen- 
tiation and resorption were investigated by measuring the TRAcP 
activity, the CTX release in the conditioned medium and by scor- 
ing the pit area. Osteoclast numbers were assessed by counting 
calcitonin receptor positive cells and by measuring TRAcP activ- 
ity in the conditioned medium. Mature osteoclasts were cultured 
on young and old bone for 9 days followed by measurement of 
osteoclast activity and number. Osteoclast adhesion was investi- 
gated by scoring TRAcP positive osteoclasts on bone slices af- 
ter 1,2 and 6 hours. The quantitative differences between young 
and old bones were assessed by measuring the amount of na- 
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tive (a-CTX) and age-modified (b-CTX) collagen type I fragments 
in decalcified, collagenase treated old and young bone slices. Im- 
munocytochemistry and ELISA were used to localize and quantify 
b-CTX and a-CTX release by osteoclasts on either young or old 
bone slices. 
Results: On young bone slices the formation of osteoclasts from 
osteoclast precursors was reduced by more than 50% compared 
to those formed on old bone (p<0.001). Osteoclastic resorption, 
as measured by b-CTX, was also reduced by more than 50% 
on young compared to old bone (p<0.001). By counting of the 
number of osteoclasts, old bones were shown to have 5 times as 
many osteoclasts as young bone (p<0.001). Osteoclast survival 
was two times higher on old bone than on young bone. Osteo- 
clasts adhered to young and old bone at equal rates. Cortical 
bone slices from old cows contained 3 times lower a-CTX/b-CTX 
ratios than those from young bones (p<0.01), further emphasiz- 
ing the quantitative difference between young and old bone. Dur- 
ing resorption the osteoclasts release a and b-CTX from both 
bone types, however, the a to b-CTX ratio is higher on young 
than old bones, whereas the total resorption level is higher on the 
old bones, indicating that osteoclasts preferentially degrade old 
bones. 
Conclusion: These data clearly show that old bones support 
osteoclastogenesis and osteoclast survival better than young 
bones. Hence, osteoclastic bone resorption on old bone is highly 
increased compared to that on young bone. Thus, the age of the 
bones might play instrumental role(s) in controlling the amount of 
resorption and thereby lead to targeted remodeling of old bones 
during the remodeling process. 
P106 
PROLIFERATION AND COLLAGEN TYPE I EXPRESSION 
OF OSTEOARTHRITIC OSTEOBLASTS ARE INDUCED BY 
CXCL12 (SDF-1) AND CXCL13 (BCA-1) CHEMOKINES 
G Lisignoli 1 , S Cristino 1 , A Piacentini 1 , C Cavallo 1 , A Facchini 1,2 
1 Lab. di Immunologia e Genetica, Istituti Ortopedici Rizzoli, 
Bologna, Italy; 2Dipto. di Medicina Interna e Gastroenterologia, 
Universita degli Studi di Bologna, Bologna, Italy 
Bone tissue homeostasis is a complex process that involves 
bone cells (i.e. osteoblasts and osteoclasts) and secreted fac- 
tors (i.e. hormones, cytokines). Evidence indicates that the pro- 
gression of joint cartilage degeneration in osteoarthritis (OA) is 
associated with subchondral bone modification. In OA patients, 
bone modifications are characterized by areas of subchondral 
sclerosis, enhanced bone density, increased subchondral bone 
metabolism, as well as increased collagen type I synthesis and 
osteophyte formations. Imbalance between osteoblast (OBs) and 
osteoclast functions as well as secretion of proinflammatory c - 
tokines, degradative nzymes and chemokines are responsible 
for bone tissue remodeling. 
To evaluate the role of CXC chemokines, CXCL8 (IL8), CXCL10 
(IP-10), CXCL12 (SDF-1) and CXCL13 (BCA-1) in bone remod- 
eling, we analysed their effects on osteoblasts obtained from 
subchondral trabecular bone tissue of osteoarthritis (OA) and 
post-traumatic (PT) patients. OBs were isolated and the expres- 
sion of CXC receptors/ligands (CXCR1/CXCL8, CXCR2/CXCL8, 
CXCR3/CXCL10, CXCR4/CXCL12, CXCR5/CXCL13) was anal- 
ysed by flow cytometry and immunocytochemistry. Functional as- 
says on CXC chemokine-treated-OBs in the presence or absence 
of their specific inhibitors were performed to analyse cellular pro- 
liferation and the enzymatic response to chemokine activation. 
The expression of chemokine ligands/receptors was also con- 
firmed in bone tissue samples by immunohistochemical naly- 
sis. Collagen type I and alkaline phosphatase mRNA expression 
were analysed on CXCL12- and CXCL13-treated OBs by Real- 
time PCR. 
OBs from both OA and PT patients expressed high levels of 
CXCR3 and CXCR5 and lower amounts of CXCR1 and CXCR4. 
CXCL12 and CXCL13, only in OBs from OA patients, induced a 
significant proliferation that was also confirmed by specific block- 
ing experiments. Moreover, OBs from OA patients released a 
higher amount of CXCL13 than those of PT patients while no 
differences were found for CXCL12. In the remodeling area of 
bone tissue samples, immunohistochemical nalysis confirmed 
that OBs expressed CXCL12/CXCR4 and CXCL13/CXCR5 both 
in OA and PT samples. CXCL12 and CXCL13 upregulated colla- 
gen type I mRNA expression in OBs from OA patients. 
These data suggest that CXCL12 and CXCL13 may directly mod- 
ulate cellular proliferation and collagen type I in OA patients, so 
contributing to the remodeling process that occurs in the evolution 
of this disease. 
P107 
ALTERATION OF CHONDROCYTE DEGRADATIVE 
PHENOTYPE IN NORMAL AND PATHOLOGICAL EQUINE 
ARTICULAR CARTILAGE 
PD Clegg 1'2, CM Redmond 2, TE Hardingham 2
1 Veterinary Clinical Sciences, University of Liverpool, Neston, 
Cheshire, 2 United Kingdom; Wellcome Trust Centre for 
Cell-Matrix Research, University of Manchester, Manchester, 
United Kingdom 
Aim: To profile degradative gene expression (MMP-1, 3, -13, 
ADAMTS-4 & -5, TIMP-1, -2, & -3) in chondrocytes from cartilage 
obtained from joints of normal and osteoarthritic (OA) horses. In 
particular to identify whether there is variation in gene expression 
with age in normal joints, as well as to document variations in 
such gene expression in different stages of OA. Furthermore to 
identify whether there are site specific variations in gene expres- 
sion between sites undergoing different loading in both normal 
and OA joints. 
Materials and Methods: Cartilage was obtained from low and 
high loaded sites of the medial femoral condyle of 15 normal 
horses aged 4-35 years old following euthanasia. Similar carti- 
lage samples were obtained form horses with acute traumatic OA 
(<3 month duration) (n=12) and Chronic OA (>3 months) (n=17). 
RNA was extracted and global cDNA libraries synthesised. Gene 
expression for relevant genes was quantified using Real Time 
PCR and normalised against GAPDH. Statistical analysis to as- 
sess the effect of age, site and disease state was performed using 
mixed effect linear regression models. 
Results: In normal joints, there was little difference in gene ex- 
pression between cartilage obtained from different loaded sites 
in the joint. There was a small but significant increase in MMP- 
13 (p<0.01) gene expression associated with increasing age. In 
OA samples there were no significant differences in any gene 
expression levels between different loaded sites within the joint. 
There were obvious perturbations in gene expression between 
normal and OA joints for a variety of genes. MMP-1 was in- 
creased (p<0.01) in acute (but not in chronic) OA, whilst MMP-3 
showed no significant difference between normal and either OA 
groups. MMP-13 was significantly increased in both acute and 
chronic OA (p<0.0001). ADAMTS-4 was significantly higher in 
both disease states, whilst ADAMTS-5 was significantly lower 
in both disease states (p<0.001). TIMP-1 was significantly up- 
regulated in both OA states (p<0.001), whilst TIMP-2 was sig- 
nificantly lower in both OA states (p<0.001). TI MP-3 was signifi- 
cantly lower in acute OA alone (p<0.01). 
Conclusion: There is little variation in degradative gene expres- 
sion with ageing in normal skeletally mature horses. In both acute 
and chronic OA there are considerable perturbations in gene ex- 
pression in comparison with normal joints, although some genes 
with similar functions are not co-regulated and show opposite 
